Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$379K Sell
33,700
-3,000
-8% -$31.9K 0.01% 703
2026
Q2
$378K Hold
36,700
– – 0.02% 707
2026
Q1
$355K Hold
36,700
– – 0.02% 672
2025
Q4
$541K Hold
36,700
– – 0.02% 527
2025
Q3
$505K Hold
36,700
– – 0.04% 381
2025
Q2
$359K Buy
36,700
+5,573
+18% +$45.2K 0.03% 439
2025
Q1
$253K Buy
31,127
+1,227
+4% +$9.6K 0.02% 527
2024
Q4
$230K Buy
29,900
+344
+1% +$3.04K 0.02% 560
2024
Q3
$256K Buy
+29,556
New +$264K 0.02% 536

Other funds holding DXR

BFC Planning's DXR Position: Q3 2026 in Review

BFC Planning reduced its Daxor (DXR) stake by 8.2% in Q3 2026, selling an estimated $31.9K and leaving 33,700 shares worth $379K. The position accounts for 0.01% of the portfolio, ranked #703.

BFC Planning first reported a position in DXR in Q3 2024 and has held it in 9 quarters since. The position peaked at $541K in Q4 2025. 15 funds tracked by Wall St. Rank hold DXR as of Q3 2026.

  • BFC Planning held 33,700 shares of Daxor worth $379K as of Q3 2026.
  • BFC Planning sold 3,000 Daxor shares in Q3 2026, an estimated $31.9K.
  • Daxor made up 0.01% of BFC Planning's portfolio in Q3 2026, its #703 holding.
  • BFC Planning first reported a position in Daxor in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Daxor position peaked at $541K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Daxor as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.